2nd Quarter - Report

EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Firm
Client
Income
—
Expenses
$410,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Policies related to health reform, structure, PBM and drug benefit requirements--HR 3590, HR 4872 Establishment of a regulatory pathway for biogenerics/biosimilars--HR 3590 Regulatory implementation issues of HITECH, (ARRA, HR 1)

LobbyistCovered position, as disclosed
JONAH C HOUTS —
ROBERT W LIVELY —
MARY M ROSADO —

Contacted: Defense, Dept of (DOD); White House Office; Food & Drug Administration (FDA); Federal Trade Commission (FTC); SENATE; Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3590 (111th), H.R. 1 (111th), H.R. 4872 (111th)

Defense DEF

H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)

LobbyistCovered position, as disclosed
NANCY GILBRIDE —
JONAH C HOUTS —
MARY M ROSADO —

Contacted: Food & Drug Administration (FDA); Congressional Budget Office (CBO); White House Office; Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC)

Bills named: H.R. 5013 (111th), H.R. 806 (111th), H.R. 5136 (111th)

Medicare/Medicaid MMM

Exclusion of specialty distributors' prompt pay discounts from the definition of average sales price Health reform proposals that impact Medicare Part D such as formulary requirements, waiver of anti-kickback statutes for generic drug copay waivers, direct negotiation, Medicaid rebate changes, PBM disclosure provisions, closing the Part D coverage gap--HR 3590 and HR 4872 (PPACA/Health care reform)

LobbyistCovered position, as disclosed
JONAH C HOUTS —
ROBERT W LIVELY —
MARY M ROSADO —

Contacted: Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); White House Office; Congressional Budget Office (CBO)

Bills named: H.R. 3590 (111th), H.R. 4872 (111th)

Pharmacy PHA

Items related to reverse settlement payments between manufacturers--HR 1706, S 369 Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489 Design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements--HR 3590, HR 4872 Policies related to restricting PBMs' ability to manage prescription drug benefits -- HR 4199 HR 5234, PBM Audit Reform and Transparency Act

LobbyistCovered position, as disclosed
JONAH C HOUTS —
ROBERT W LIVELY —
MARY M ROSADO —

Contacted: Defense, Dept of (DOD); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 4872 (111th), H.R. 1706 (111th), H.R. 4489 (111th), H.R. 3590 (111th), H.R. 5234 (111th), H.R. 4199 (111th)

Labor Issues/Antitrust/Workplace LBR

H.R. 1204--Pharmacies Antitrust carve out legislation

LobbyistCovered position, as disclosed
JONAH C HOUTS —
ROBERT W LIVELY —
MARY M ROSADO —

Contacted: Food & Drug Administration (FDA); Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); SENATE; HOUSE OF REPRESENTATIVES; White House Office; Defense, Dept of (DOD)

Bills named: H.R. 1204 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.